Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Dana-Farber/Brigham and Women’s Cancer Center to launch nation’s first tissue-screening program for immunotherapies
Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) will become the first treatment center in the United States to routinely test patients’ tumor tissue to determine whether the cancer is likely to respond to immunotherapies. The testing, expected to begin in early…
